Tag: Alexion
Boehringer joins trial program to advance treatments for AML
The trial will employ the latest genomic technology to change the paradigm for how the deadly cancer is treated.
Malloy: First Five Plus has created nearly 3,800 jobs
The jobs program's participating companies have invested nearly $1.3 billion in new infrastructure and human capital.